| Serum serotonin concentration in lean and obese dogs with myxomatous mitral valve disease |
|
Kyu-Tae Kim1, Hee-Myung Park2, Changbaig Hyun3, Kyoung-Won Seo1, Kun-Ho Song1 |
1College of Veterinary Medicine, Chungnam National University
2College of Veterinary Medicine, Konkuk University
3College of Veterinary Medicine, Kangwon National University |
|
|
| Abstract |
|
The aim of the present study is to investigate the potential influence of obesity as a factor in 5-hydroxytryptamine (5-HT) concentration in myxomatous mitral valve disease (MMVD) dogs. Fifty-five client-owned dogs were enrolled in a randomized trial. Dogs were classified by echocardiography into healthy (control), mild, and moderate to severe MMVD groups. Each group was subclassified by using a 9-point body condition score (BCS); lean (BCS 5-6/9) and obese groups (BCS 7.5-9/9). Dogs with moderate to severe MMVD had lower serotonin (5-HT) concentrations than the control group (p = 0.03). Dogs with moderate to severe MMVD (p = 0.017) had lower serum 5-HT concentrations than the control group in the obese group (BCS 7.5-9/9). Significant difference was found between the lean and obese groups (p = 0.015) which are not consider severe in the MMVD group. These results suggested that 5-HT concentration was decreased with the increasing severity of MMVD, and obesity might be taken into consideration when interpreting the serotonin concentration in MMVD dogs. |
| Key Words:
5-HT concentration, body condition score, dogs, myxomatous mitral valve disease, obesity |
|
PDF Links
Full text via DOI
Download Citation
